Given the expanding role of GLP-1As in psychiatric treatment, psychiatric pharmacists should recognize appropriate patients for this medication class and explain both its benefits and risks. This session will discuss the differences in GLP-1As for weight loss treatment, risks, and creation of a treatment plan when using these agents in the setting of an eating disorder. #2025AAPPSummit #psychpharm #aapp #bcpp